Category: Health News

Evaluating comparative effectiveness of Pfizer-BioNtech and Moderna vaccines among US veterans

The coronavirus disease 2019 (COVID-19) disease has been caused by the rapid outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has already claimed more than 5.23 million lives. Scientists have worked extremely hard to develop vaccines, many of which have received emergency use authorization from global regulatory bodies. Two mRNA-based vaccines (BNT162b2

New Jersey GOP Lawmakers Defy Vaccine Mandate

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Disorder and confusion erupted in the halls outside the New Jersey Assembly on Thursday as several Republican lawmakers defied a new requirement to show proof of COVID-19 vaccination or a negative test and were blocked by state troopers— albeit briefly —

USPSTF Reaffirms Advice on Preventing Cavities in Preschoolers

NEW YORK (Reuters Health) – The U.S. Preventive Services Task Force (USPSTF) continues to recommend that pediatricians and other primary-care doctors apply fluoride varnish to infants’ primary teeth soon after they erupt. This grade-B recommendation is consistent with the 2014 recommendation from the task force. The task force also continues to recommend that primary-care doctors

Hemostatic Powder Noninferior in Nonvariceal Upper GI Bleeds

TC-325, a bentonite-derived hemostatic powder, was not inferior to standard therapy for the endoscopic management of acute nonvariceal upper GI bleeding, according to a new study. The findings from the study, lead investigator and study author James Y.W. Lau, MD, of the Prince of Wales Hospital in Hong Kong, said in an interview, suggest TC-325

Cream Improves Plaque Psoriasis but Can Spark Local Side Effects

NEW YORK (Reuters Health) – A cream containing Dermavant Sciences’ experimental drug tapinarof significantly improves plaque psoriasis in about a third of patients, but it may also spark headaches and other side effects such as folliculitis and contact dermatitis, according to results of two phase-3 trials. The once-daily topical aryl-hydrocarbon-receptor-modulating agent is currently being evaluated

Long term vaccine response following Pfizer COVID-19 vaccination in hemodialysis patients

In a recent study published on the preprint server medRxiv*, researchers discuss the long-term humoral immune responses in hemodialysis patients after being vaccinated with the severe acute respiratory syndrome 2 (SARS-CoV-2) BNT162b2 messenger ribonucleic acid (mRNA) vaccine (Pfizer-BioNTech). To this end, 40% of the patients regressed to a borderline or negative antibody status at six

An illuminated 3D tour of lower back pain

Back pain affects many people at some point in their lives, and a common cause is damage to the squishy discs or flexible, rubbery tissues of the spine. However, observing this damage at an early stage is difficult with current imaging methods. Now, researchers reporting in ACS Nano can see microscopic soft tissue destruction in animal spines

Exploring the effectiveness of telehealth in opioid use disorder

The majority of individuals with opioid use disorder (OUD) face access barriers to evidence-based treatment. While the COVID-19 pandemic offered an opportunity to address OUD treatment access barriers by allowing for expanded use of telehealth, is it not yet clear if this technology will help eliminate those barriers or exacerbate pre-existing treatment inequities. A study

Supreme Court Leaves Texas Abortion Law in Place

This is a breaking news story and will be updated with additional details and perspective as warranted. In a highly anticipated decision, the U.S. Supreme Court ruled today that the controversial Texas abortion law that restricts the procedure to women pregnant for 6 weeks or less may continue to be enforced, but allowed for state

FDA Expands Pembrolizumab Approval for Advanced Melanoma

The US Food and Drug Administration has approved pembrolizumab (Keytruda) for the adjuvant treatment of stage IIB and IIC melanoma after complete resection in adults and children over age 12 years. The FDA also extended the approval to those with stage III disease. The FDA approval on December 3 was based on first interim findings